Literature DB >> 26864105

Stable long-term cultures of self-renewing B cells and their applications.

Mark J Kwakkenbos1, Pauline M van Helden1, Tim Beaumont1, Hergen Spits1,2.   

Abstract

Monoclonal antibodies are essential therapeutics and diagnostics in a large number of diseases. Moreover, they are essential tools in all sectors of life sciences. Although the great majority of monoclonal antibodies currently in use are of mouse origin, the use of human B cells to generate monoclonal antibodies is increasing as new techniques to tap the human B cell repertoire are rapidly emerging. Cloned lines of immortalized human B cells are ideal sources of monoclonal antibodies. In this review, we summarize our studies to the regulation of the replicative life span, differentiation, and maturation of B cells that led to the development of a platform that uses immortalization of human B cells by in vitro genetic modification for antibody development. We describe a number of human antibodies that were isolated using this platform and the application of the technique in other species. We also discuss the use of immortalized B cells as antigen-presenting cells for the discovery of tumor neoantigens.
© 2016 The Authors. Immunological Reviews Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  B cells; BCL6; antibodies; germinal center; rabbit

Mesh:

Substances:

Year:  2016        PMID: 26864105      PMCID: PMC4755196          DOI: 10.1111/imr.12395

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  85 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  EB virus-induced B lymphocyte cell lines producing specific antibody.

Authors:  M Steinitz; G Klein; S Koskimies; O Makel
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

3.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

4.  A common solution to group 2 influenza virus neutralization.

Authors:  Robert H E Friesen; Peter S Lee; Esther J M Stoop; Ryan M B Hoffman; Damian C Ekiert; Gira Bhabha; Wenli Yu; Jarek Juraszek; Wouter Koudstaal; Mandy Jongeneelen; Hans J W M Korse; Carla Ophorst; Els C M Brinkman-van der Linden; Mark Throsby; Mark J Kwakkenbos; Arjen Q Bakker; Tim Beaumont; Hergen Spits; Ted Kwaks; Ronald Vogels; Andrew B Ward; Jaap Goudsmit; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-11       Impact factor: 11.205

5.  Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.

Authors:  Eric Tran; Simon Turcotte; Alena Gros; Paul F Robbins; Yong-Chen Lu; Mark E Dudley; John R Wunderlich; Robert P Somerville; Katherine Hogan; Christian S Hinrichs; Maria R Parkhurst; James C Yang; Steven A Rosenberg
Journal:  Science       Date:  2014-05-09       Impact factor: 47.728

6.  Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation.

Authors:  Chainarong Tunyaplin; A L Shaffer; Cristina D Angelin-Duclos; Xin Yu; Louis M Staudt; Kathryn L Calame
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire.

Authors:  Mark J Kwakkenbos; Arjen Q Bakker; Pauline M van Helden; Koen Wagner; Etsuko Yasuda; Hergen Spits; Tim Beaumont
Journal:  Methods       Date:  2013-07-15       Impact factor: 3.608

Review 8.  STAT3 is a central regulator of lymphocyte differentiation and function.

Authors:  Alisa Kane; Elissa K Deenick; Cindy S Ma; Matthew C Cook; Gulbu Uzel; Stuart G Tangye
Journal:  Curr Opin Immunol       Date:  2014-03-06       Impact factor: 7.486

9.  A robust high throughput platform to generate functional recombinant monoclonal antibodies using rabbit B cells from peripheral blood.

Authors:  Stefan Seeber; Francesca Ros; Irmgard Thorey; Georg Tiefenthaler; Klaus Kaluza; Valeria Lifke; Jens André Alexander Fischer; Stefan Klostermann; Josef Endl; Erhard Kopetzki; Achal Pashine; Basile Siewe; Brigitte Kaluza; Josef Platzer; Sonja Offner
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

10.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

Authors:  Elisabetta Traggiai; Stephan Becker; Kanta Subbarao; Larissa Kolesnikova; Yasushi Uematsu; Maria Rita Gismondo; Brian R Murphy; Rino Rappuoli; Antonio Lanzavecchia
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440

View more
  20 in total

1.  Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.

Authors:  David R McIlwain; Han Chen; Zainab Rahil; Neda Hajiakhoond Bidoki; Sizun Jiang; Zach Bjornson; Nikita S Kolhatkar; C Josefina Martinez; Brice Gaudillière; Julien Hedou; Nilanjan Mukherjee; Christian M Schürch; Angelica Trejo; Melton Affrime; Bonnie Bock; Kenneth Kim; David Liebowitz; Nima Aghaeepour; Sean N Tucker; Garry P Nolan
Journal:  Cell Host Microbe       Date:  2021-11-15       Impact factor: 21.023

2.  Landscape of coordinated immune responses to H1N1 challenge in humans.

Authors:  Zainab Rahil; Rebecca Leylek; Christian M Schürch; Han Chen; Zach Bjornson-Hooper; Shannon R Christensen; Pier Federico Gherardini; Salil S Bhate; Matthew H Spitzer; Gabriela K Fragiadakis; Nilanjan Mukherjee; Nelson Kim; Sizun Jiang; Jennifer Yo; Brice Gaudilliere; Melton Affrime; Bonnie Bock; Scott E Hensley; Juliana Idoyaga; Nima Aghaeepour; Kenneth Kim; Garry P Nolan; David R McIlwain
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 3.  Effective high-throughput isolation of fully human antibodies targeting infectious pathogens.

Authors:  Lutz Gieselmann; Christoph Kreer; Meryem Seda Ercanoglu; Nathalie Lehnen; Matthias Zehner; Philipp Schommers; Julian Potthoff; Henning Gruell; Florian Klein
Journal:  Nat Protoc       Date:  2021-05-25       Impact factor: 13.491

4.  Continuous Culture of Mouse Primary B Lymphocytes by Forced Expression of Bach2.

Authors:  Joel Finney; Garnett Kelsoe
Journal:  J Immunol       Date:  2021-08-13       Impact factor: 5.426

5.  Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001.

Authors:  Nathan Holman; Jason T Weinfurter; Trevor R Harsla; Roger W Wiseman; Aaron J Belli; Anthony J Michaels; Keith A Reimann; Robert I DeMars; Matthew R Reynolds
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

Review 6.  Advances in the Isolation of Specific Monoclonal Rabbit Antibodies.

Authors:  Zaibao Zhang; Huijuan Liu; Qian Guan; Lei Wang; Hongyu Yuan
Journal:  Front Immunol       Date:  2017-05-05       Impact factor: 7.561

7.  Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.

Authors:  M Gordon Joyce; Adam K Wheatley; Kayvon Modjarrad
Journal:  Cell       Date:  2020-07-09       Impact factor: 41.582

8.  Optimisation of ex vivo memory B cell expansion/differentiation for interrogation of rare peripheral memory B cell subset responses.

Authors:  Luke Muir; Paul F McKay; Velislava N Petrova; Oleksiy V Klymenko; Sven Kratochvil; Christopher L Pinder; Paul Kellam; Robin J Shattock
Journal:  Wellcome Open Res       Date:  2017-10-05

Review 9.  Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.

Authors:  Urai Chaisri; Wanpen Chaicumpa
Journal:  Biomed Res Int       Date:  2018-05-28       Impact factor: 3.411

Review 10.  Recent advances in veterinary applications of structural vaccinology.

Authors:  Bryan Charleston; Simon P Graham
Journal:  Curr Opin Virol       Date:  2018-03-16       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.